TREACE MEDICAL CONCEPTS, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $212.7M | $209.4M | $187.1M | $141.8M | $94.4M |
| Gross profit | $169.8M | $168.3M | $151.9M | $116.3M | $77.5M |
| Operating income | -$54.2M | -$55.7M | -$51.4M | -$34.8M | -$16.5M |
| Operating expenses | $223.9M | $224.0M | $203.4M | $151.2M | $94.0M |
| Cost of revenue | $42.9M | $41.1M | $35.2M | $25.5M | $16.9M |
| Cash from operations | -$16.0M | -$37.2M | -$34.6M | -$30.6M | -$17.2M |
| Capital expenditure | $13.5M | $11.6M | $11.5M | $14.8M | $2.7M |
| Free cash flow | -$29.5M | -$48.8M | -$46.0M | -$45.5M | -$19.9M |
| Impairments | $0 | $0 | $0 | $300,000 | $0 |
| Total assets | $190.6M | $217.1M | $251.9M | $159.0M | $140.8M |
| Total liabilities | $103.2M | $104.2M | $114.0M | $98.5M | $47.7M |
| Total debt | $60.0M | $54.0M | $54.0M | $54.0M | $30.0M |
Shares outstanding 64.9M · Free float 75.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.